Numerous developments are enabling ever more personalised leukemia treatments with lower toxicity Published on 19/06/2023 Recent studies have sought to demonstrate the effectiveness of new targeted therapies, such as FLT3 or menin inhibitors, and cellular therapy such as CAR-T in ever earlier scenarios
Improves the identification of genetic alterations in leukemia, allowing treatment to be personalized, improving its effectiveness Published on 20/06/2022 Depending on the type of leukemia, patients will have different genetic alterations or mutations that determine the progress of treatment
A decade of hope begins for the treatment of acute myeloid leukemia thanks to new treatments like FLT3 inhibitors Published on 21/06/2021 New drugs, like FLT3 inhibitors, improve survival rates in people with acute myeloid leukemia, acting on altered intracellular signaling pathways that allow cancer cells to grow